Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Simbolo

Showing results (21-30 of 89) with videos related to

Pageof 9
Sort By:
Anti-Cancer Drugs|January 9, 2015
Complete remission with sunitinib in a poor-risk patient with metastatic renal cell carcinoma: the fine balance between toxicity and efficacyFrancesco Massari, Chiara Ciccarese, Davide Bimbatti, et al.
Updates in Surgery|February 6, 2020
Multigene mutational profiling of biliary tract cancer is related to the pattern of recurrence in surgically resected patientsSimone Conci, Andrea Ruzzenente, Michele Simbolo, et al.
Hereditary Cancer in Clinical Practice|August 25, 2015
Next-generation sequencing for genetic testing of familial colorectal cancer syndromesMichele Simbolo, Andrea Mafficini, Marco Agostini, et al.
Annals of Surgical Oncology|January 1, 2016
Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected PatientsAndrea Ruzzenente, Matteo Fassan, Simone Conci, et al.
Virchows Archiv : an International Journal of Pathology|June 24, 2021
H3K27me3 immunostaining is diagnostic and prognostic in diffuse gliomas with oligodendroglial or mixed oligoastrocytic morphologySerena Ammendola, Nicolò Caldonazzi, Michele Simbolo, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 25, 2019
Patterns of gene mutations in bile duct cancers: is it time to overcome the anatomical classification?Fabio Bagante, Andrea Ruzzenente, Simone Conci, et al.
BMC Gastroenterology|May 8, 2020
Exosomal miRNA signatures of pancreatic lesionsCaterina Vicentini, Federica Calore, Giovanni Nigita, et al.
Annals of Surgery|August 5, 2022
Poorly Cohesive Gastric Cancers Showing the Transcriptomic Hallmarks of Epithelial-Mesenchymal Transition Behave AggressivelyMaria Bencivenga, Michele Simbolo, Chiara Ciaparrone, et al.
Diagnostics (Basel, Switzerland)|April 30, 2021
Evaluation of Correlations between Genetic Variants and High-Resolution Computed Tomography Patterns in Idiopathic Pulmonary FibrosisElisa Baratella, Barbara Ruaro, Fabiola Giudici, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|November 24, 2019
Diffuse gliomas in patients aged 55 years or over: A suggestion for IDH mutation testingValeria Barresi, Albino Eccher, Michele Simbolo, et al.
Pageof 9

Showing results (21-30 of 89) with videos related to

Sort By:
Pageof 9
Anti-Cancer Drugs|January 9, 2015
Complete remission with sunitinib in a poor-risk patient with metastatic renal cell carcinoma: the fine balance between toxicity and efficacyFrancesco Massari, Chiara Ciccarese, Davide Bimbatti, et al.
Updates in Surgery|February 6, 2020
Multigene mutational profiling of biliary tract cancer is related to the pattern of recurrence in surgically resected patientsSimone Conci, Andrea Ruzzenente, Michele Simbolo, et al.
Hereditary Cancer in Clinical Practice|August 25, 2015
Next-generation sequencing for genetic testing of familial colorectal cancer syndromesMichele Simbolo, Andrea Mafficini, Marco Agostini, et al.
Annals of Surgical Oncology|January 1, 2016
Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected PatientsAndrea Ruzzenente, Matteo Fassan, Simone Conci, et al.
Virchows Archiv : an International Journal of Pathology|June 24, 2021
H3K27me3 immunostaining is diagnostic and prognostic in diffuse gliomas with oligodendroglial or mixed oligoastrocytic morphologySerena Ammendola, Nicolò Caldonazzi, Michele Simbolo, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 25, 2019
Patterns of gene mutations in bile duct cancers: is it time to overcome the anatomical classification?Fabio Bagante, Andrea Ruzzenente, Simone Conci, et al.
BMC Gastroenterology|May 8, 2020
Exosomal miRNA signatures of pancreatic lesionsCaterina Vicentini, Federica Calore, Giovanni Nigita, et al.
Annals of Surgery|August 5, 2022
Poorly Cohesive Gastric Cancers Showing the Transcriptomic Hallmarks of Epithelial-Mesenchymal Transition Behave AggressivelyMaria Bencivenga, Michele Simbolo, Chiara Ciaparrone, et al.
Diagnostics (Basel, Switzerland)|April 30, 2021
Evaluation of Correlations between Genetic Variants and High-Resolution Computed Tomography Patterns in Idiopathic Pulmonary FibrosisElisa Baratella, Barbara Ruaro, Fabiola Giudici, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|November 24, 2019
Diffuse gliomas in patients aged 55 years or over: A suggestion for IDH mutation testingValeria Barresi, Albino Eccher, Michele Simbolo, et al.
Pageof 9